ID   PGLD_CAMJE              Reviewed;         195 AA.
AC   Q0P9D1;
DT   29-MAY-2013, integrated into UniProtKB/Swiss-Prot.
DT   19-SEP-2006, sequence version 1.
DT   07-JAN-2015, entry version 54.
DE   RecName: Full=UDP-N-acetylbacillosamine N-acetyltransferase;
DE            EC=2.3.1.203;
DE   AltName: Full=Protein glycosylation D;
DE   AltName: Full=UDP-4-amino-4,6-dideoxy-N-acetyl-alpha-D-glucosamine N-acetyltransferase;
GN   Name=pglD; OrderedLocusNames=Cj1123c;
OS   Campylobacter jejuni subsp. jejuni serotype O:2 (strain NCTC 11168).
OC   Bacteria; Proteobacteria; Epsilonproteobacteria; Campylobacterales;
OC   Campylobacteraceae; Campylobacter.
OX   NCBI_TaxID=192222;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=NCTC 11168;
RX   PubMed=10688204; DOI=10.1038/35001088;
RA   Parkhill J., Wren B.W., Mungall K.L., Ketley J.M., Churcher C.M.,
RA   Basham D., Chillingworth T., Davies R.M., Feltwell T., Holroyd S.,
RA   Jagels K., Karlyshev A.V., Moule S., Pallen M.J., Penn C.W.,
RA   Quail M.A., Rajandream M.A., Rutherford K.M., van Vliet A.H.M.,
RA   Whitehead S., Barrell B.G.;
RT   "The genome sequence of the food-borne pathogen Campylobacter jejuni
RT   reveals hypervariable sequences.";
RL   Nature 403:665-668(2000).
RN   [2]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND
RP   PATHWAY.
RC   STRAIN=NCTC 11168;
RX   PubMed=17087520; DOI=10.1021/bi061456h;
RA   Olivier N.B., Chen M.M., Behr J.R., Imperiali B.;
RT   "In vitro biosynthesis of UDP-N,N'-diacetylbacillosamine by enzymes of
RT   the Campylobacter jejuni general protein glycosylation system.";
RL   Biochemistry 45:13659-13669(2006).
RN   [3]
RP   FUNCTION.
RC   STRAIN=NCTC 11168;
RX   PubMed=19448740; DOI=10.1139/o09-002;
RA   Demendi M., Creuzenet C.;
RT   "Cj1123c (PglD), a multifaceted acetyltransferase from Campylobacter
RT   jejuni.";
RL   Biochem. Cell Biol. 87:469-483(2009).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (2.20 ANGSTROMS) OF 2-195.
RA   Jin X., Bera A., Wasserman S., Smith D., Sauder J.M., Burley S.K.,
RA   Shapiro L.;
RT   "Crystal structure of putative transferase from Campylobacter jejuni
RT   subsp. jejuni NCTC 11168.";
RL   Submitted (OCT-2006) to the PDB data bank.
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 2-195 IN COMPLEX WITH
RP   COENZYME A, SUBUNIT, AND MUTAGENESIS OF ASN-118; GLU-124; HIS-125 AND
RP   HIS-134.
RC   STRAIN=NCTC 11168;
RX   PubMed=18198901; DOI=10.1021/bi702032r;
RA   Rangarajan E.S., Ruane K.M., Sulea T., Watson D.C., Proteau A.,
RA   Leclerc S., Cygler M., Matte A., Young N.M.;
RT   "Structure and active site residues of PglD, an N-acetyltransferase
RT   from the bacillosamine synthetic pathway required for N-glycan
RT   synthesis in Campylobacter jejuni.";
RL   Biochemistry 47:1827-1836(2008).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (1.77 ANGSTROMS) IN COMPLEX WITH
RP   UDP-4-AMINO-SUGAR AND ACETYL-COA, SUBUNIT, MUTAGENESIS OF HIS-15;
RP   HIS-125 AND HIS-134, REACTION MECHANISM, ACTIVE SITE, AND SITE.
RC   STRAIN=NCTC 11168;
RX   PubMed=18667421; DOI=10.1074/jbc.M801207200;
RA   Olivier N.B., Imperiali B.;
RT   "Crystal structure and catalytic mechanism of PglD from Campylobacter
RT   jejuni.";
RL   J. Biol. Chem. 283:27937-27946(2008).
CC   -!- FUNCTION: Acetyltransferase that modifies the UDP-4-amino-sugar to
CC       form UDP-N,N'-diacetylbacillosamine in the N-linked protein
CC       glycosylation pathway. {ECO:0000269|PubMed:17087520,
CC       ECO:0000269|PubMed:19448740}.
CC   -!- CATALYTIC ACTIVITY: Acetyl-CoA + UDP-N-acetylbacillosamine = CoA +
CC       UDP-N,N'-diacetylbacillosamine. {ECO:0000269|PubMed:17087520}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=1.0 mM for UDP-N-acetylbacillosamine
CC         {ECO:0000269|PubMed:17087520, ECO:0000269|PubMed:18667421};
CC         KM=0.41 mM for UDP-N-acetylbacillosamine
CC         {ECO:0000269|PubMed:17087520};
CC         Vmax=14700 nmol/sec/mg enzyme {ECO:0000269|PubMed:17087520,
CC         ECO:0000269|PubMed:18667421};
CC         Note=kcat is 483000 min(-1) (PubMed:17087520). Kcat is 314 sec(-
CC         1) (PubMed:18667421). {ECO:0000269|PubMed:17087520,
CC         ECO:0000269|PubMed:18667421};
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC       {ECO:0000269|PubMed:17087520}.
CC   -!- SUBUNIT: Homotrimer. {ECO:0000269|PubMed:18198901,
CC       ECO:0000269|PubMed:18667421}.
CC   -!- MISCELLANEOUS: N-linked protein glycosylation in C.jejuni consists
CC       in the transfer of a heptasaccharide (GalNAc-alpha1,4-GalNAc-
CC       alpha1,4-(Glcbeta1,3)-GalNAc-alpha1,4-GalNAc-alpha1,4-GalNAc-
CC       alpha1,3-bacillosamine) from a membrane-anchored
CC       undecaprenylpyrophosphate (Und-PP)-linked donor to the Asn side
CC       chain of proteins at the Asn-X-Ser/Thr motif.
CC       {ECO:0000305|PubMed:17087520}.
CC   -!- SIMILARITY: Belongs to the transferase hexapeptide repeat family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL111168; CAL35240.1; -; Genomic_DNA.
DR   PIR; F81316; F81316.
DR   RefSeq; YP_002344516.1; NC_002163.1.
DR   PDB; 2NPO; X-ray; 2.20 A; A=2-195.
DR   PDB; 2VHE; X-ray; 1.80 A; A/B=2-195.
DR   PDB; 3BFP; X-ray; 1.75 A; A=2-195.
DR   PDB; 3BSS; X-ray; 2.30 A; A=1-195.
DR   PDB; 3BSW; X-ray; 1.77 A; A=1-195.
DR   PDB; 3BSY; X-ray; 1.80 A; A/B/C=1-195.
DR   PDBsum; 2NPO; -.
DR   PDBsum; 2VHE; -.
DR   PDBsum; 3BFP; -.
DR   PDBsum; 3BSS; -.
DR   PDBsum; 3BSW; -.
DR   PDBsum; 3BSY; -.
DR   ProteinModelPortal; Q0P9D1; -.
DR   SMR; Q0P9D1; 2-195.
DR   IntAct; Q0P9D1; 3.
DR   STRING; 192222.Cj1123c; -.
DR   EnsemblBacteria; CAL35240; CAL35240; Cj1123c.
DR   GeneID; 905414; -.
DR   KEGG; cje:Cj1123c; -.
DR   PATRIC; 20059204; VBICamJej33762_1105.
DR   HOGENOM; HOG000253005; -.
DR   KO; K15913; -.
DR   OMA; GMKFEST; -.
DR   OrthoDB; EOG6QRW7J; -.
DR   BioCyc; CJEJ192222:GJTS-1096-MONOMER; -.
DR   BioCyc; MetaCyc:MONOMER-17320; -.
DR   UniPathway; UPA00378; -.
DR   EvolutionaryTrace; Q0P9D1; -.
DR   Proteomes; UP000000799; Chromosome.
DR   GO; GO:0016747; F:transferase activity, transferring acyl groups other than amino-acyl groups; IDA:UniProtKB.
DR   GO; GO:0018279; P:protein N-linked glycosylation via asparagine; IDA:UniProtKB.
DR   Gene3D; 3.40.50.20; -; 1.
DR   InterPro; IPR001451; Hexapep_transf.
DR   InterPro; IPR016185; PreATP-grasp_dom.
DR   InterPro; IPR020019; Sia_OAcTrfase_NeuD_NnaD.
DR   InterPro; IPR011004; Trimer_LpxA-like.
DR   Pfam; PF00132; Hexapep; 1.
DR   SUPFAM; SSF51161; SSF51161; 1.
DR   TIGRFAMs; TIGR03570; NeuD_NnaD; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acyltransferase; Complete proteome; Reference proteome;
KW   Transferase.
FT   CHAIN         1    195       UDP-N-acetylbacillosamine N-
FT                                acetyltransferase.
FT                                /FTId=PRO_0000422585.
FT   REGION       13     15       Substrate binding.
FT   REGION       35     36       Substrate binding.
FT   ACT_SITE    125    125       Proton acceptor.
FT                                {ECO:0000269|PubMed:18667421}.
FT   BINDING      56     56       Substrate; via amide nitrogen.
FT   BINDING     134    134       Acetyl-CoA.
FT                                {ECO:0000269|PubMed:18667421}.
FT   BINDING     155    155       Acetyl-CoA; via amide nitrogen.
FT                                {ECO:0000269|PubMed:18667421}.
FT   BINDING     173    173       Acetyl-CoA; via amide nitrogen and
FT                                carbonyl oxygen.
FT                                {ECO:0000269|PubMed:18667421}.
FT   SITE        126    126       Increases basicity of active site His.
FT   MUTAGEN      15     15       H->A: Induces a higher KM and approximate
FT                                3-fold decrease in the turnover number.
FT                                {ECO:0000269|PubMed:18667421}.
FT   MUTAGEN     118    118       N->A: Reduction in catalytic activity.
FT                                {ECO:0000269|PubMed:18198901}.
FT   MUTAGEN     124    124       E->A: Reduction in catalytic activity.
FT                                {ECO:0000269|PubMed:18198901}.
FT   MUTAGEN     125    125       H->A: Strong reduction in catalytic
FT                                activity. {ECO:0000269|PubMed:18198901,
FT                                ECO:0000269|PubMed:18667421}.
FT   MUTAGEN     134    134       H->A: Slight reduction in catalytic
FT                                activity. {ECO:0000269|PubMed:18198901,
FT                                ECO:0000269|PubMed:18667421}.
FT   STRAND        5     10       {ECO:0000244|PDB:3BFP}.
FT   HELIX        15     26       {ECO:0000244|PDB:3BFP}.
FT   STRAND       29     34       {ECO:0000244|PDB:3BFP}.
FT   TURN         36     38       {ECO:0000244|PDB:2VHE}.
FT   HELIX        40     45       {ECO:0000244|PDB:3BSW}.
FT   STRAND       50     53       {ECO:0000244|PDB:3BFP}.
FT   HELIX        58     69       {ECO:0000244|PDB:3BFP}.
FT   TURN         70     72       {ECO:0000244|PDB:3BFP}.
FT   STRAND       89     91       {ECO:0000244|PDB:3BSW}.
FT   STRAND      181    183       {ECO:0000244|PDB:3BSS}.
FT   STRAND      186    188       {ECO:0000244|PDB:2VHE}.
FT   TURN        189    192       {ECO:0000244|PDB:2VHE}.
SQ   SEQUENCE   195 AA;  21148 MW;  8C6312D439AE90E2 CRC64;
     MARTEKIYIY GASGHGLVCE DVAKNMGYKE CIFLDDFKGM KFESTLPKYD FFIAIGNNEI
     RKKIYQKISE NGFKIVNLIH KSALISPSAI VEENAGILIM PYVVINAKAK IEKGVILNTS
     SVIEHECVIG EFSHVSVGAK CAGNVKIGKN CFLGINSCVL PNLSLADDSI LGGGATLVKN
     QDEKGVFVGV PAKRM
//
